title: [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors].
abstract: We reviewed the efficacy and complications of transcatheter arterial chemoembolization using degradable starch microspheres (DSM) for primary neuroendocrine tumors of the liver or liver metastases from gastrointestinal neuroendocrine tumors in ten patients. The rate of complete and partial response was 70.0%. The one year and two year survival rate was 77.8% respectively, with a median survival time of 852 days (28.4 months). All symptoms and laboratory data related to treatment were acceptable. It is thought that DSM-TACE is an effective treatment for inoperable liver neuroendocrine tumors or liver metastases from gastrointestinal neuroendocrine tumors.
authors.affiliation: Department of Gastroenterology, Cancer Institute Ariake Hospital.
authors.forename: Tadashi
authors.initials: T
authors.lastname: Fujisaki
authors.forename: Takaaki
authors.initials: T
authors.lastname: Ikari
authors.forename: Akira
authors.initials: A
authors.lastname: Kamei
authors.forename: Kouichi
authors.initials: K
authors.lastname: Takano
authors.forename: Kensuke
authors.initials: K
authors.lastname: Kuraoka
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Yoshimoto
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Hirasawa
authors.forename: Shingo
authors.initials: S
authors.lastname: Asahara
mesh_terms: D000368:Aged; D002404:Catheterization; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000473:pathology*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000628:therapy*; D013213:Starch / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: C083286:degradable starch microspheres; D013213:Starch